Both Ki-ras mutation and hepatocyte growth factor (HGF) receptor Met overexpression occur at high frequency in colon cancer. This study investigates the transcriptional changes induced by Ki-ras oncogene and HGF/Met signaling activation in colon cancer cell lines in vitro and in vivo. The model system used in these studies included the DLD-1 colon cancer cell line with a mutated Ki-ras allele, and the DKO-4 cell line generated from DLD-1, with its mutant Ki-ras allele inactivated by targeted disruption. These cell lines were transduced with cDNAs of full-length Met receptor. Microarray transcriptional profiling was conducted on cell lines stimulated with HGF, as well as on tumor xenograft tissues. Overlapping genes between in vitro and in vivo microarray data sets were selected as a subset of HGF/Met and Ki-ras oncogene-regulated targets. Using the Online Predicted Human Interaction Database, novel HGF/Met and Ki-ras regulated proteins with putative functional linkage were identified. Novel proteins identified included histone acetyltransferase 1, phosphoribosyl pyrophosphate synthetase 2, chaperonin containing TCP1, subunit 8, CSE1 chromosome segregation 1-like (yeast)/cellular apoptosis susceptibility (mammals), CCR4-NOT transcription complex, subunit 8, and cyclin H. Transcript levels for these Met-signaling targets were correlated with Met expression levels, and were significantly elevated in both primary and metastatic human colorectal cancer samples compared to normal colorectal mucosa. These genes represent novel Met and/or Ki-ras transcriptionally coregulated genes with a high degree of validation in human colorectal cancers.
Introduction
Colorectal carcinogenesis is characterized by a welldelineated series of genetic mutations and aberrant gene expression events (Fearon and Vogelstein, 1990) . Ki-ras oncogene activation and the overexpression of growth factor receptors on the cell surface have been shown to play important roles in colon cancer progression (Shirasawa et al., 1993; Fazekas et al., 2000) . Ki-ras is constitutively activated by mutations in 40-50% of colorectal cancers (Martinez-Garza et al., 1999; Tortola et al., 1999) . Met is a receptor tyrosine kinase that critically regulates cellular proliferation, motility, morphogenesis and apoptosis (Jiang et al., 1999) . Met receptor overexpression has been reported in greater than 50% of primary colorectal adenocarcinomas (Liu et al., 1992; Di Renzo et al., 1995) .
One of the key mediators of hepatocyte growth factor (HGF)/Met signaling is the Ras family membraneassociated guanine nucleotide exchange proteins (Graziani et al., 1993; Vojtek and Der, 1998) . Both the HGF/ Met interaction and Ras oncogene may lead to activation of several downstream signaling cascades including the Raf/MEK/MAPK (Halaban et al., 1992) and the PI3K/PKB (Graziani et al., 1991; RodriguezViciana et al., 1994) pathways, both of which are capable of inducing transcriptional events. Additionally, the Met receptor is capable of regulating transcription independent of Ras, through STAT-3 (Boccaccio et al., 1998 ), b-catenin (Danilkovitch-Miagkova et al., 2001 Monga et al., 2002) and through Crk/JNK (Conner et al., 1999; Garcia-Guzman et al., 1999) pathways. Consequently, there is a potential for both Rasdependent and -independent transcriptional events downstream from HGF/Met signaling.
We have previously investigated the effect of combined Ki-ras mutation and Met overexpression in the progression of colon cancer (Seiden Long et al., 2003) . The model employed the colon cancer cell line DLD-1 with an activating Ki-ras mutation, as well as its derivative cell line DKO-4 that has had a targeted disruption of the mutant Ki-ras allele but retains the remaining wild-type Ki-ras allele (Shirasawa et al., 1993) . Overexpression of Met in these lines results in spontaneous activation of the receptor. Met receptor overexpression enhanced tumorigenicity only in the cell line with Ki-ras mutation but not in its Ki-ras oncogene inactivated counterpart, thus identifying ras oncogene as a modulator of Met signaling activity in colon cancer cells. We report here the transcriptional consequences of HGF/Met and Ras signaling in colon cancer cell lines DLD-1 and DKO-4 using a novel approach that interfaces expression microarray profiling data with a protein-protein interaction (PPI) database. The approach led to the identification of novel subset of HGF/Met and Ras regulated genes, which are elevated both in primary human colorectal cancers as well as metastatic lesions.
Results

Expression profiling of cell lines in vitro
Spotted microarrays containing 1718 cDNA clones (http://www.microarray.ca) were used to track the transcriptional changes induced by HGF stimulation of both the DLD-1 (Ki-ras G13D ) cell line and its mutant Ki-ras inactivated clone DKO-4. The cells were serum starved 24 h prior to the start of all experimental time points (0 h), and total RNA was serially isolated from cells stimulated by HGF over a 48-h time course. RNA of samples from all time points were then referenced against those isolated at 0 h. Control RNA was also isolated from serum-starved cells at the equivalent 6 h time point (30 h post serum starvation). For both cell lines, the sample from the 6 h control time point demonstrated no significant changes from the 0 h sample. However, by 12 h, the serum-starved control samples began to show significant changes, which complicated the interpretation of growth factor effects in the latter part of the time course (data not shown). Thus, results from analyses using only data from less than 6 h post-HGF stimulation are reported here. Following data filtration (see Materials and methods section), the retained 177 out of 1718 genes clustered into two major groups of genes ( Figure 1a ). The largest cluster included genes that were downregulated in both DLD-1 and DKO-4 by HGF stimulation, but the changes were less pronounced in DLD-1 cells treated by HGF. The smaller cluster contained genes that were upregulated by HGF stimulation in both cell lines, as well as genes that were unchanged in the DLD-1 cells but were substantially upregulated by HGF in the DKO-4 cells. Overall, the genes transcriptionally regulated by HGF in both DLD-1 and DKO-4 cells were similar, but the magnitude of changes appeared greater in DKO-4 cells with functional wild-type Ki-ras genotype.
Expression profiling of tumor tissues in vivo Using the U133A Affymetrix oligonucleotide microarrays containing approximately 14 500 unique transcripts, global transcriptional profiling was performed on xenograft tumor tissues formed by the DLD-1 and Figure 1 Comparative gene expression profiling between in vitro and in vivo sample sources. (a) Gene expression changes in DLD-1 and DKO-4 cells stimulated by HGF from cDNA microarray data. Cells were grown to 50% confluence and serum starved for 24 h, and then stimulated by HGF. Total RNA was extracted at 0, 15, 30 min, 1, 3 and 6 h after growth factor addition. DLD-1 and DKO-4 24 h serum-starved samples were used for reference RNA. Serum starvation controls were carried out for each cell line at 0 min and 6 h in the time course. Genes (n ¼ 177) have been hierarchically clustered with the Eisen Cluster and TreeView programs and displayed on a color scale, with red representing positive values (upregulated) and green representing negative (downregulated) log 2 converted values. Gray represents areas with no data. (b) Gene expression changes in DLD-1, DLD-1 Met, DKO-4 and DKO-4 Met tumor xenograft tissues from Affymetrix array data. All samples have been referenced to DLD-1. Data have been expressed as log 2 ratios with respect to reference. Genes (n ¼ 1190) have been hierarchically clustered and displayed as in (a). (c) Component planes from BTSVQ cluster analysis using transcript expression levels in DLD-1, DLD-1 Met, DKO-4 and DKO-4 Met tumor xenograft tissues from Affymetrix array data for all present genes. DKO-4 cell lines with and without forced Met overexpression. All expression levels were referenced to DLD-1 control tissue and filtered to include only genes that were altered at least two-fold across the data set. There were 1190 unique transcripts that survived this filtration, 93 of which showed four-fold or greater variability in one of the cell line xenograft systems (Supplementary Table 1 ). Hierarchical clustering of the 1190 transcripts showed that expression changes between DLD-1 compared to DKO-4 tumors were similar to those induced by Met overexpression in the DLD-1 or DKO-4 samples (Figure 1b) . DKO-4 tumors also demonstrated transcriptional changes similar to both DLD-1 and DKO-4 tumors. The global expression data were analysed using a Binary Tree-Structured Vector Quantization (BTSVQ) algorithm, and the results were visualized using self-organizing map (SOM) component planes (Sultan et al., 2002) . This also demonstrated that the differences in expression profiles between the DLD-1 and DKO-4 tumors were more pronounced than between these lines and their corresponding Met-overexpressing derivatives. The results indicate that expression changes induced by Ki-ras oncogenic activation are greater than those induced by Met overexpression in tumors formed by these colon cancer lines (Figure 1c) . However, similar to the in vitro findings (Figure 1a ), the magnitude of transcriptional changes consequent to Met overexpression in DKO-4 tumors appeared exaggerated compared to that in DLD-1 tumors. Overall, there were far greater transcriptional upregulation than downregulation events in response to Met signaling in vivo. This finding was in contrast to the results of cell line cDNA microarray profiling results, which primarily showed the majority of genes being transcriptionally downregulated in response to HGF stimulation.
Common transcripts regulated by HGF/Met signaling To select genes for further analysis and validation, the filtered gene lists from both in vitro and in vivo data sets were analyzed for intersection using their Unigene ID. The rationale for choosing this method of focused data analysis stemmed from the similar trends observed in both data sets in terms of global transcriptional changes. Of the 177 transcripts found significantly altered by HGF stimulation in vitro and the 1190 transcripts altered by at least two-fold in vivo, 20 unique transcripts were found to overlap (Table 1 and Figure 2a ). Among these, eight had published information with respect to potential interactions with other proteins. These included adenylyl cyclase-associated protein (CAP), Cyclin H (CCNH), chaperonin containing TCP1, subunit 8 (CCT8), CCR4-NOT transcription complex, subunit 8 (CNOT8), CSE1 chromosome segregation 1-like (yeast)/cellular apoptosis susceptibility (mammals) (CSE1L/CAS), histone acetyltransferase 1 (HAT1), phosphoribosyl pyrophosphate synthetase 2 (PRPS2) and a member of the RAS family (RAB11A). Using a consolidated database of PPIs that integrates publicly available protein interaction data sets from Mus musculus, Caenorhabditis elegans, Drosophia melanogaster, Saccharomyces cerevisiae and Homo sapiens sources and mapping them to human protein orthologs (http://ophid.utoronto.ca), proteins that potentially interacted with the eight transcripts were identified (Supplementary Table 2 well as additional putative roles in translation, transport and cellular organization.
Met-associated molecular interaction network
To investigate if these putative PPIs could be integrated further into a Met-regulated 'molecular interaction network', PathwayAssist s software was used to query any additional PPIs that these Met target genes have previously been associated with. PathwayAssist s software uses a curated database compiled from published literature to generate putative interaction networks. Similar to HAT1, CCNH and CNOT8 have been functionally linked to the histone modification pathway through various intermediaries (Kaufman et al., 1995; Verreault et al., 1996; Bhattacharjee et al., 2001) .
Furthermore, CCNH associates with MYC (Eberhardy and Farnham, 2001) , which binds to the helicase RUVBL2/Tip49 (Wood et al., 2000; Dugan et al., 2002) . RUVBL2 was identified by Online Predicted Human Interaction Database (OPHID) as interacting with CCT8 and CNOT8. Integration of this additional published data may lead to a more comprehensive and integrated molecular interaction network (Figure 2c ).
Validation of transcriptional changes
The six interacting genes identified from microarray data were selected for further validation by real-time quantitative RT-PCR. For in vivo samples, RNA from eight independent xenograft tumor samples was utilized for each group (representative samples Figure 3a and b). Since the Affymetrix analyses used pooled tumor RNA samples, it was anticipated that sample heterogeneity could become apparent when the original three as well as an additional five samples were individually analyzed. This form of validation allows for the expansion of sample number for statistical comparison between data sets. For HAT1, CAS, CCT8 and CCNH, significant differences in transcriptional changes were observed between DLD-1, DLD-1 Met and DKO-4 Met samples. For PRPS2, the only significant difference was between DKO-4 and DKO-4 Met. For CNOT8, the addition of extra samples resulted in a loss of significant differences detected by microarray study. Validation by real-time RT-PCR was also conducted on RNA samples that were originally used for cDNA microarray experiments. For DLD-1 cells, HAT1, PRPS2, CAS, CNOT8, CCT8 and CCNH transcript levels were all significantly upregulated within 3 h after HGF stimulation ( Figure 3c ). Overall, the findings demonstrate a concordance between in vitro and in vivo data sets.
Altered HAT1 and CAS protein expression in xenograft tumors
The targets chosen for validation at the protein level were contingent upon the availability of specific antibodies. Using quantitative image analysis, the induction of CAS and HAT1 by Met overexpression was validated on xenograft tumor tissue specimens. Tumor histology indicated large, central necrotic regions of tissue surrounded by viable tumor cells containing very little interspersed stromal component (data not shown). The tumor cells were distinguished in the 4,6-diamidino-2-phenylindole (DAPI) channel by their nuclear morphology on a low-resolution Â 5 scan of the tumor section. Using the Â 5 scan as a map to identify viable tumor regions, five representative high-resolution ( Â 20) images in the Cy3 (antibody of interest) channel were captured for each tumor and four tumors per sample set (20 images in total). For HAT1 and CAS, the images were quantified by thresholding the staining intensity to capture the strongest signal. CAS demonstrated primarily nuclear localization in xenograft tissues, while HAT1 was both nuclear and, to a lesser extent, cytoplasmic. In samples expressing HAT1 and CAS at high levels, >95% of tumor cells in any captured field demonstrated nuclear staining. This indicates that HAT1 and CAS are coexpressed in these tissues (data not shown). HAT1 protein levels were significantly increased in Ki-ras knockout DKO-4 tumors, but Metoverexpression alone did not seem to cause significant increases in either Ki-ras mutant or Ki-ras knockout tissue (Figure 3d ). For CAS, increases in protein levels were observed in both Met overexpressing and Ki-ras knockout cells (Figure 3e ), indicating that CAS levels were both Met and Ki-ras dependent in these tissues.
Transcriptional targets of HGF/Met and Ki-ras signaling in colorectal carcinogenesis
The relative levels of mRNA transcripts for HAT1, CAS, PRPS2, CNOT8, CCT8 and CCNH were evaluated in 30 normal human tissues, 63 primary colorectal cancer and 30 metastatic lesions. RNA levels from all six transcriptional targets identified by microarray analysis are significantly elevated between normal and primary carcinoma tissues ( Figure 4 and Table 2 ). Transcript levels are additionally elevated between primary carcinoma and metastases, indicating that more aggressive lesions are associated with greater expression levels of these transcripts (Figure 4b-d) . The pattern of transcript expression correlates strongly with the expression of Met receptor in these tissues, indicating the potential for a single mechanism of transcriptional regulation for all these targets.
In addition to primary transcriptional targets identified by microarray analysis, several other transcripts (PSMC3, IPO4, RUVBL2 and IDH3A - Figure 2c) were also chosen for validation. These other transcripts were only identified by PPI interactions in OPHID and PathwayAssist. Remarkably, three of these targets also showed correlation with Met mRNA expression levels (Figure 4e ), as well as upregulation in colorectal primary and metastatic tumors compared to the normal mucosa ( Figure 4f ).
Altered CAS and HAT1 protein levels in human colorectal cancer samples Human tissue arrays were evaluated for CAS and HAT1 protein expression levels by immunohistochemistry. Nuclear and cytoplasmic staining of both CAS and HAT1 are seen in human tissues. In normal colon, both HAT1 and CAS staining was strongest at the crypt base, where there is the greatest amount of cellular proliferation. In tumors, both HAT1 and CAS staining was diffuse throughout the tissue. For CAS, both nuclear and cytoplasmic staining was increased in primary colorectal cancer samples and metastases (Figure 5b and e) compared to the normal colonic epithelium (Figure 5a and e). HAT1 nuclear staining was similar between normal and primary tumors, but was decreased in metastases. HAT1 cytoplasmic staining showed dramatic increase in primary and metastatic tumors (Figure 5d and e) compared to the normal mucosa (Figure 5c and e) . Analysis of all four sample sets by Fisher's exact test (Po0.0001) indicates that there is an extremely low probability that the patterns observed are random.
Discussion
Using a global gene expression profiling strategy, we have shown that, in the DLD-1 colon cancer cell line, the primary signaling pathway that mediates transcriptional regulation of gene expression downstream from the Met receptor is the Ras pathway. Met overexpression or HGF stimulation did not appear to induce a large number of unique transcriptional changes that differed significantly from those induced by Ki-ras oncogene alone. Rather, the effects were broadly overlapping (Figure 1a-c) . Our findings also demonstrate that a potent oncogene such as Ki-ras may lower the global transcriptional activity of cancer cells and insulate them from large transcriptional alterations induced by growth factor stimulation. Nevertheless, these cells remain receptive to transcriptional activation induced by the HGF/Met signaling, and such modest amount of transcriptional alterations may still impact on enhancing the tumorigenicity of cells with Ki-ras mutation, but not of cells with wild-type Ki-ras genotype (Seiden-Long et al., 2003) . In this study, in vivo growth appears to strongly influence transcriptional profiling of the colorectal cancer cells, as is demonstrated by the strong contrast between upregulation and downregulation events between in vitro and in vivo data sets. It has been shown that the extracellular matrix (ECM) upon which cells are growing can significantly alter transcriptional profiles (Yarwood and Woodgett, 2001 ). There is increasing evidence that HGF/Met does not exist in solitary confinement on the cell surface, but rather as a component of a larger, multi-component, signaling complex. In fact, HGF/Met signaling is intimately linked with that of other ECM-associated signaling proteins on the cell surface, such as integrins, plexins and CD44 (Bertotti and Comoglio, 2003) . We identified 1190 transcripts that were differentially expressed two-fold or more in vivo following Met overexpression of DLD-1 and DKO-4 cell lines. Comparison of our in vivo (Affymetrix derived) differentially expressed transcripts/genes with two previously published lists of microarray-based HGF-induced gene expression profiles (Gerritsen et al., 2003) revealed at least 19 genes that overlapped between the three studies (Table 3) (Balkovetz et al., 2004) . These genes that were revealed in multiple independent studies using different cell lines are likely to represent additional true HGF/ Met-regulated genes. The paucity of overlap genes with the studies performed on HUVEC cells is likely due to the incomplete list of HGF-induced genes that was published (Gerritsen et al., 2003) . Divergent gene expression changes induced by the same factor could also be cell type or cell line dependent.
Microarray data sets were integrated with OPHID in an attempt to further expand the scope of our understanding of expression changes induced by specific genes. Application of the limited in vitro and in vivo overlapped genes to this analytical approach identified six genes that belong to a hypothetical network of function at the protein level. The transcriptional upregulation of these six target genes by HGF/Met/ Ki-ras signaling was confirmed using quantitative realtime RT-PCR, both in vitro and in vivo (Figure 3) . It is notable that the transcriptional patterns for HAT1 and CAS in Figure 3a -b differ from the protein expression pattern in Figure 3d -e. This underscores the importance of validation of targets by quantification of protein levels as well as RNA levels. However, this type of analysis is also limited by the availability of antibodies suitable for immunohistochemistry.
Transcriptional regulation was also validated in primary human colorectal tissue samples (Table 2) . It was even more exciting to discover that several (three of four evaluated) of the interacting proteins that linked the six direct targets of HGF/Met/RAS signaling were Genes with changes that were two-fold or greater are included (Balkovetz et al., 2004) .
b
Genes with changes that were 1.5-fold and with Po0.1 were included (Gerritsen et al., 2003) . also transcriptionally correlated with the expression levels of Met receptor, and were significantly upregulated during colorectal carcinogenesis (Table 2 ). This would indicate that microarray data can be further enriched by PPI information and that PPI is an invaluable hypothesis-generating tool to expand the scope of information offered by microarrays alone. None of these genes/proteins has previously been reported as associated with either HGF/Met signaling; thus, they represent novel downstream targets of both HGF/Met and Ras signaling cascades, especially during human colorectal carcinogenesis.
Networking of target genes by OPHID and PathwayAssist s allows us to identify similarly regulated proteins that have related, but otherwise subtly connected, roles in cellular processes. The relationships between these proteins and their connection with transcriptional regulation can be quite complex, and not immediately obvious from initial observation. The existence of multiple interacting proteins that interconnect these target genes at a functional level provides mechanistic insight for relating transcriptional networks to biological consequences. Novel targets have reported roles ranging from chromatin assembly and nuclear import/export to direct association with the cellular transcription complexes.
Cytoplasmic HAT1 acetylates newly synthesized histone H4 and to a lesser extent H2A, putatively promoting their transportation into the nucleus, deposition onto newly replicated DNA and the assembly of chromatin (Roth et al., 2001) . The relationship between HAT1, Ras and Met/HGF signaling provides one important link between chromatin assembly or remodeling and oncogenesis. The HAT1 gene has a putative bipartite nuclear localization signal, and has been shown to localize in the nucleus of S-phase cells (Verreault et al., 1998) . The HAT1 holoenzyme also includes the retinoblastoma protein-binding protein 7 (RBBP7 or RBap46), a putative negative regulator of Ras function (Qian and Lee, 1995) , and another target identified by PPI. Tissue array staining patterns indicate that, in tumor tissues and metastases, HAT1 is increased in the cytoplasm rather than the nucleus ( Figure 5) ; thus, in this context, may have dominant role in cytoplasmic histone acetylation.
Another protein that is predicted to interact with HAT1 is IPO4, which, together with importin-b, binds to the nuclear localization signal (NLS) of many important proteins to shuffle them into the nucleus (Behrens et al., 2003) . CAS together with Ran-GTP regulate the re-export of IPO4 from the nucleus, and the overexpression of CAS prompts the retention of imported proteins in the nucleus. The CAS gene is located on chromosome 20q13, a locus often amplified in colon and breast cancers (Brinkmann et al., 1996) . In addition to its role in transcription, an alternative role in intracellular junction formation for CAS has been reported in HT29 cells (Jiang et al., 2002) . This process is dependent on E-cadherin and regulates cellular polarity and inhibits cell growth in vitro (Jiang et al., 2002; Jiang and Liao, 2004) . The intracellular junction formation mediated by CAS and E-cadherin may have a role in promoting metastases in human tissues. In human tumor tissues, there is an elevation in both nuclear and cytoplasmic CAS staining ( Figure 5) ; thus, CAS may have more than one function in the progression of colorectal carcinoma.
The relationship between upregulation of these genes and the tumor biology could be different in xenograft models and human tumor tissue samples. In DLD-1 and DKO-4 tumors, differences in primary tumor growth rate are observed, which are Ki-ras and Met dependent. These transcripts are more strongly elevated in tumors, which show reduced growth rates in vivo. However, the impact of Ki-ras and Met on tumor metastasis cannot be observed in a subcutaneous model. In contrast to tumor xenograft data, an increase in all six identified transcripts is observed for human primary tumor and metastatic tissues (Table 2) . Between primary and metastatic tissues, there is a marked increase in transcript levels, indicating a correlation between metastasis and transcript levels. This pattern correlates with Met expression levels in these tissues ( Table 2 ), indicating that, in human samples, there is a strong relationship between upregulation of Met and associated transcriptional targets which does not require Ki-ras mutation (samples were all randomly selected and Ki-ras status is unknown). The immunohistochemistry data from tissue arrays for HAT1 and CAS quite closely reiterate the observed transcriptional patterns in human tissue samples. Future studies will focus on determining if elevation of these transcripts is a causative factor in promoting colon cancer metastasis, or a marker of malignant transformation. For the former scenario, identification of a whole group of transcripts, which are regulated in similar manner, may provide important prognostic information.
In summary, this study has provided new insight into the convergence of transcriptional signaling pathways in tumor cells and has further emphasized the significant impact a single mutant Ki-ras allele can exert in terms of regulating the overall levels of transcripts within the cell. We have demonstrated that the analysis of common genes with in vitro and in vivo systems has several key advantages when prioritizing targets derived from genome-wide experiments for future studies. The novel targets of HGF/Met and Ki-ras signaling identified both in model systems and in human tumor tissues in this study all have some link to transcriptional activation, which provides information that may help to explain global transcriptional patterns observed in array profiles. The selection of targets for validation based on PPIs provides a compelling way for identifying target genes that may be linked at functional level.
Materials and methods
Reagents, cell lines and patient tissues Human recombinant HGF was purchased from R&D (Minneapolis, MN). DLD-1 and DKO-4 colon epithelial cells were routinely cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) (Gibco-BRL, Grand Island, NY). DLD-1, DLD-1-Met, DKO-4 and DKO-4-Met mouse tumor xenograft tissues were generated as described previously (Seiden Long et al., 2003) . HAT1 and CAS antibodies were purchased from Santa-Cruz Biotechnology (Santa Cruz, CA), and anti-goat-HRP/antigoat-Cy3 from Jackson Immunological (West Grove, PA).
Patient tissue samples were obtained from the University Health Network (UHN) Tissue Bank, following approval of this project by the UHN Research Ethics Board. All tissues were collected within 30 min of resection and snap-frozen in liquid nitrogen; their qualities have been verified by histology. Tissues included 30 normal colorectal mucosa, 63 primary colorectal cancers, and 30 metastatic colorectal cancers. The tumor samples were from 38 Dukes' B and 25 Dukes' C patients, and the normal mucosa was from the corresponding tissue of a subset of these patients. Metastatic tumors were from liver (22 cases) and lung (8 cases) metastasectomy specimens. Tissue arrays were constructed from paraffin blocks of formalin-fixed tissues that were taken for quality control of the banked tissue, and thus were representative of the frozen tissues. Minimums of two cores were taken from each block.
Growth factor stimulation and cell lysis Subconfluent (30-50%) cultures were washed twice with Hanks' buffered saline solution (HBSS) and incubated in serum-free or supplement-free medium overnight. At 2 h prior to the experiment, the cells were once more washed with HBSS, and the media replaced by fresh serum-free medium. The experiment was initiated by adding HGF (10 ng/ml) to the media, and total cellular RNA was isolated by guanidine isothiocyanate-phenol extraction at 15, 30 min, 1, 3, 6, 12, 24 and 48 h after growth factor addition (Tsao et al., 1998) . RNA was also isolated from serum-free control cultures at 6, 12, 24, and 48 h.
Probe preparation for cDNA microarray experiments Total cellular RNA (10-20 mg) was reverse transcribed in the presence of Amino-Allyl dUTP (Sigma, Oakville, ON) using the manufacturer's recommended protocol for Superscript II reverse transcriptase (Invitrogen Inc., Ontario, Canada). Reactions were purified using Microcon-30 columns (Millipore, Bedford, USA). Samples were dried using a Speedvac concentrator, resuspended in 0.1 M sodium bicarbonate (pH ¼ 9.0), and divided for reciprocal labeling. Cy3 and Cy5 dyes (Pharmacia, Piscataway, NJ) resuspended in DMSO were added to each 4.5 ml aliquot of cDNA. For one set of aliquots the DLD-1 or DKO-4 reference was labeled with Cy5 dye, while test samples were labeled with Cy3 dye, and for the other set of aliquots DLD-1 or DKO-4 reference was labeled with Cy3 dye, while test samples were labeled with Cy5 dye. Coupling was performed at room temperature in darkness for 45 min. Reactions were quenched by addition of 4 M hydroxylamine and incubated for 15 min at room temperature in the dark. Cy3 and Cy5 reactions were then combined for each set of reference and test samples, and unincorporated nucleotides were removed using a High Pure PCR purification kit (Roche, Laval, QC). Probes were dried using a Speedvac concentrator prior to resuspension.
cDNA microarray hybridization Glass 1.7K3 cDNA human arrays were purchased from the Ontario Cancer Institute microarray facility (http://www. microarrays.ca/). These arrays represent 1718 cDNA EST sequences of known genes derived from IMAGE consortium clone sets. Arrays were pre-hybridized for 1 h at 371C in DIGeasy hybridization buffer (Roche, Laval, QC) mixed with 0.5 mg/ml yeast tRNA, 0.5 mg/ml salmon sperm DNA and 1% bovine serum albumin in humid hybridization chambers. Slides were washed with double-deionized water and then dried with isopropanol. Probes were resuspended in DIGeasy hybridization buffer (Roche, Laval, QC) for 5 min at 651C, then hybridized to glass arrays overnight at 371C in humid hybridization chambers. Slides were washed the next day six times for 5 min at room temperature in 0.1 Â SSC, 0.1% SDS, and then two times with 0.1 Â SSC. Slides were dried by centrifugation prior to scanning. All experimental samples were reciprocally labeled and hybridized to arrays in duplicate.
Scanning and analysis of data Slides were scanned using a Genepix 4000 scanner (Axon Instruments Inc., Union City, USA), and Tiff files analyzed using Quantarray image analysis software (Perkin-Elmer, Ontario, Canada) Cy3 and Cy5 channels were normalized by sub-array intensity, and ratios were calculated as test sample divided by reference sample on each array. Ratio values are shown as an average of four spots: two spots for each cDNA on a single array, and two arrays for each test sample (with Cy3 and Cy5 reversed for replicates). DLD-1 and DKO-4 cells at 0 min self-self (control) hybridization ratios were analyzed by frequency distribution, demonstrating that the mean ratio for control data was approximately 1, and that 72 standard deviations from the mean was in the range of 0.70-1.3 (data not shown). Clustering was performed using the Eisen Cluster and TreeView software package (Eisen et al., 1998) . All selected DLD-1 or DKO-4 gene ratios were log 2 transformed and filtered in the following fashion. Data for the DLD-1 and DKO-4 growth factor time course were filtered to remove any genes that did not show at least one time point with an up-or downregulation of at least four-fold with respect to reference and an absolute range of four-fold change across the gene. These filters left 177 out of 1718 genes to be clustered for the growth factor stimulations. All groups were clustered using an unsupervised hierarchical algorithm. Data are displayed by color representation of log 2 ratio data, with green representing gene downregulation with respect to reference RNA and red representing gene upregulation with respect to reference RNA.
Unsupervised clustering was also performed using a BTSVQ algorithm (Sultan et al., 2002; Liu et al., 2004; Barrios-Rodiles et al., 2005) . BTSVQ combines SOMs and iterative k-means clustering in a complementary fashion. The algorithm partitions data using a k-means algorithm in sample space, where k is kept constant at 2. Iteratively applying the algorithm and using evaluation of variance as a stopping criterion, it generates a binary tree. For each level of the binary tree, the genes are ranked both with respect to the likelihood of the gene being differentially expressed across all the samples in the same cluster and t-statistics. This provides an accurate method of excluding genes with variable expression across samples, as well as genes with low significance, and thus enables selection of the most differentiating genes between clusters. The SOM algorithm is then used to cluster the gene space, to produce pseudocolor component planes for visualization (see Figure 1c ). During training, SOM algorithm generates bestmatching vectors for the data and randomly distributes them on the 2D map. The SOM neighborhood function brings similar groups spatially close to each other. We have used a Gaussian neighborhood function with medium radius. The cluster structure in gene space is then visualized using component planes of the already computed SOM. Thus, the gene expression is visualized as color intensity.
Oligonucleotide array analysis Total RNA was isolated from xenograft primary tumor tissue by guanadinium/phenol extraction (Tsao et al., 1998) . RNA was then further purified using an RNeasy kit (Qiagen Inc., Ontario, Canada). Quality of RNA preparation was confirmed using an Agilent Bioanalyzer (Agilent Technologies, Palo Alto, CA). The arrays utilized in these experiments were U133A human oligonucleotide arrays (Affymetrix Inc., Santa Clara, CA). The U133A array contains >22 000 probe sets representing 18 400 transcripts (14 500 unique genes). Each array sample consists of 20 mg pooled total RNA from three separate tumor tissue samples, combined in equal concentration. Sample labeling and array hybridizations were conducted at The Centre of Applied Genomics (Hospital for Sick Children, Toronto, Canada, http://tcag.bioinfo.sickkids.on.ca/index. php?pagename ¼ microarray.php). Sample RNA in vitro transcription, labeling and hybridization were conducted by standard Affymetrix protocols, described in detail on their website. (http://www.affymetrix.com/support/technical/manual/ expression_manual.affx). Raw array image data were analyzed using Affymetrix MAS 5.0 software. All arrays have been scaled to a mean intensity of 150, and ratios have been generated to compare all samples to DLD-1 control array data.
All DLD-1 or DKO-4 gene ratios were log 2 transformed and filtered in the following fashion. All genes that were deemed absent by the MAS 5.0 software were removed from consideration. Data for the DLD-1 and DKO-4 growth factor time course were filtered to remove any genes that did not show an absolute range of two-fold change across the gene. These filters left 1190 out of B11 000 present transcripts to be clustered. All data were clustered using an unsupervised hierarchical algorithm (Eisen et al., 1998) . Data are displayed by color representation of log 2 ratio data, with green representing gene downregulation with respect to reference RNA and red representing gene upregulation with respect to reference RNA.
Measurement of mRNA transcript levels by real-time RT-PCR RNA was isolated as described above for the xenograft tumors. In all, 4 mg of total cellular RNA was reversed transcribed using Superscript II reverse transcriptase (Invitrogen Inc., Ontario, Canada). A 10 ng equivalent of cDNA was used for each quantitative PCR assay performed with the ABI PRISM 7700 Sequence Detection System, using SYBR green 2 Â master mix (Perkin-Elmer Applied Biosystems, Foster City, CA). Two independent assays were performed in duplicate on cDNA from each cell line grown in tissue culture and stimulated with HGF. For tumor xenograft tissue, N ¼ 8 individual tumor samples were quantified in duplicate. For human tissues, the data set consisted of 30 normal mucosa, 63 primary colorectal cancers and 30 metastatic lesions. The sequences of gene transcripts that corresponded to the Affymetrix probe set were obtained from GenBank accession numbers listed on the Affymetrix website (http://www. affymetrix.com) and intron-spanning primer sets for PCR amplifications were designed to these sequences using the Primer Express software (Perkin-Elmer Applied Biosystems, Foster City, CA). Predicted PCR product sequences were checked using BLAST for recognition of target and nontarget sequences. Dissociation curves were performed as routine verification in order to check the primers for amplification of a single band, and template dilution standard curves (5-log range) were conducted with each primer set to verify a linear relationship between template concentration and C T values (R 2 >0.9, data not shown, primer sequences in Supplementary   Table 3) . RNA for standard curve generation was isolated from subconfluent DKO-4 Met cell line grown in tissue culture. Absolute transcript concentrations were calculated using standard curves for each primer set. Relative ratios were then calculated for each sample set in a manner similar to cDNA microarray ratios to allow relative comparison between data sets. For human tissue samples, ratios were calculated using an average of normal tissue values for each primer set.
PPI analysis
The OPHID of predicted human PPIs was used to generate protein interaction data for target genes from microarray experiments (Brown and Jurisica, 2005) . OPHID (http:// ophid.utoronto.ca) provides a unified resource for exploring the interactome by combining 19 454 known human interactions from BIND, DIP, HPRD and MINT with 23 889 interactions predicted by interolog mapping from S. cerevisiae, C. elegans, D. melanogaster, and M. musculus. OPHID was searched using Unigene IDs of identified target genes from microarray data. The PathwayAssist s software (http:// www.ariadnegenomics.com/products/pathway.html) was purchased from Stratagene (La Jolla, CA). The reported interactions were further verified by reviewing the original publications.
Immunohistochemistry and image analysis Formalin-fixed, paraffin-embedded tumor xenograft tissue sections were analyzed with HAT1 and CAS primary antibodies and anti-goat-Cy3-labeled secondary antibody. Paraffin sections at were cut at 4 mm thickness, dried in 601C oven, de-waxed in xylene and re-hydrated. Microwave antigen retrieval was performed in MicroMed T/T (Hacker Instruments, Fairfield, NJ) oven for 10 min at 1201C. Primary antibody incubation was performed with CAS (1:500) or HAT1 (1:2000) goat polyclonal antibody for 16 h at room temperature. Negative control was incubated in phosphatebuffered saline (PBS). Slides were rinsed three times in PBS. Secondary antibody incubation was performed with Cy3-conjugated anti-goat IgG (1:100) or anti-goat-HRP for 60 min at room temperature, and slides were rinsed three times with PBS. For normal immunohistochemistry samples, immunoreactivity was visualized by incubation in Nova Red substrate (Vector Laboratories, Burlingame, CA) for 5 min. For fluorescence applications, slides were mounted on Vectashield mounting medium containing DAPI (Vector Laboratories, Burlingame, CA) immediately prior to viewing.
Four xenograft tumors per sample were analyzed in cross section for HAT1 and CAS levels by capturing five representative fields per tumor in regions of the tissue containing only living tumor cells (20 fields per sample total). Imaging employed the Zeiss Axiovert 200M inverted stage microscope with a FLUAR 20 Â /0.75 NA (DIC) objective (Carl Zeiss Inc., Tornwood, NY) illuminated by a 100 W HBO Mercury lamp. Images were captured at 8-bit grayscale resolution by a Coolsnap HQ CCD camera (Roper Scientific Inc., Trenton, NJ). Stroma and necrotic tissue were excluded from consideration by examining distinct nuclear morphology as seen by DAPI staining in a low-resolution (FLUAR 5 Â /0.25 NA objective) scan of the tumor. Using Image Pro software (Media Cybernetics, Silver Spring, MD), images were threshold gated to quantify staining by sum of integrated optical density (IOD), which is defined as average pixel intensity Â area, and background fluorescence was subtracted using a secondary antibody negative control.
Tissue array cores were scored for immunostaining intensity of nuclear and cytoplasmic CAS and HAT1 in normal colonic mucosa epithelial cells and tumor cells, using the 0 to 3 scores representing absent, weak, moderate or strong, respectively. Samples that showed 2 or 3 staining intensity were scored as positive samples.
